Literature DB >> 26253522

Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains.

Louise Cullen1, Rebecca Weiser2, Tomasz Olszak3, Rita F Maldonado4, Ana S Moreira4, Lisa Slachmuylders5, Gilles Brackman5, Tsvetelina S Paunova-Krasteva6, Paulina Zarnowiec7, Grzegorz Czerwonka7, James Reilly1, Pavel Drevinek8, Wieslaw Kaca7, Oto Melter8, Anthony De Soyza9, Audrey Perry10, Craig Winstanley11, Stoyanka R Stoitsova6, Rob Lavigne12, Eshwar Mahenthiralingam2, Isabel Sá-Correia4, Tom Coenye5, Zuzanna Drulis-Kawa3, Daria Augustyniak3, Miguel A Valvano13, Siobhán McClean1.   

Abstract

Pseudomonas aeruginosa causes chronic lung infections in people with cystic fibrosis (CF) and acute opportunistic infections in people without CF. Forty-two P. aeruginosa strains from a range of clinical and environmental sources were collated into a single reference strain panel to harmonise research on this diverse opportunistic pathogen. To facilitate further harmonized and comparable research on P. aeruginosa, we characterized the panel strains for growth rates, motility, virulence in the Galleria mellonella infection model, pyocyanin and alginate production, mucoid phenotype, LPS pattern, biofilm formation, urease activity, and antimicrobial and phage susceptibilities. Phenotypic diversity across the P. aeruginosa panel was apparent for all phenotypes examined, agreeing with the marked variability seen in this species. However, except for growth rate, the phenotypic diversity among strains from CF versus non-CF sources was comparable. CF strains were less virulent in the G. mellonella model than non-CF strains (P = 0.037). Transmissible CF strains generally lacked O-antigen, produced less pyocyanin and had low virulence in G. mellonella. Furthermore, in the three sets of sequential CF strains, virulence, O-antigen expression and pyocyanin production were higher in the earlier isolate compared to the isolate obtained later in infection. Overall, this full phenotypic characterization of the defined panel of P. aeruginosa strains increases our understanding of the virulence and pathogenesis of P. aeruginosa and may provide a valuable resource for the testing of novel therapies against this problematic pathogen.

Entities:  

Mesh:

Year:  2015        PMID: 26253522     DOI: 10.1099/mic.0.000155

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  25 in total

Review 1.  Is There Potential for Repurposing Statins as Novel Antimicrobials?

Authors:  Emma Hennessy; Claire Adams; F Jerry Reen; Fergal O'Gara
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 2.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

3.  The putative bacterial oxygen sensor Pseudomonas prolyl hydroxylase (PPHD) suppresses antibiotic resistance and pathogenicity in Pseudomonas aeruginosa.

Authors:  Bettina Schaible; Bianca Crifo; Kirsten Schaffer; Cormac T Taylor
Journal:  J Biol Chem       Date:  2019-12-11       Impact factor: 5.157

4.  A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development.

Authors:  Francois Lebreton; Erik Snesrud; Lindsey Hall; Emma Mills; Madeline Galac; Jason Stam; Ana Ong; Rosslyn Maybank; Yoon I Kwak; Sheila Johnson; Michael Julius; Melissa Ly; Brett Swierczewski; Paige E Waterman; Mary Hinkle; Anthony Jones; Emil Lesho; Jason W Bennett; Patrick McGann
Journal:  JAC Antimicrob Resist       Date:  2021-12-10

5.  Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.

Authors:  Ashley L Cooney; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Mallory R Stroik; Linda S Powers; Nick D Gansemer; David K Meyerholz; Michael J Welsh; David A Stoltz; Patrick L Sinn; Paul B McCray
Journal:  JCI Insight       Date:  2016-09-08

6.  Diversity of free-living amoebae in soils and their associated human opportunistic bacteria.

Authors:  Elodie Denet; Bénédicte Coupat-Goutaland; Sylvie Nazaret; Michel Pélandakis; Sabine Favre-Bonté
Journal:  Parasitol Res       Date:  2017-10-07       Impact factor: 2.289

7.  Bile signalling promotes chronic respiratory infections and antibiotic tolerance.

Authors:  F Jerry Reen; Stephanie Flynn; David F Woods; Niall Dunphy; Muireann Ní Chróinín; David Mullane; Stephen Stick; Claire Adams; Fergal O'Gara
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

8.  The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.

Authors:  Bartosz Roszniowski; Agnieszka Latka; Barbara Maciejewska; Dieter Vandenheuvel; Tomasz Olszak; Yves Briers; Giles S Holt; Miguel A Valvano; Rob Lavigne; Darren L Smith; Zuzanna Drulis-Kawa
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-21       Impact factor: 4.813

9.  A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.

Authors:  Katarzyna Danis-Wlodarczyk; Dieter Vandenheuvel; Ho Bin Jang; Yves Briers; Tomasz Olszak; Michal Arabski; Slawomir Wasik; Marcin Drabik; Gerard Higgins; Jean Tyrrell; Brian J Harvey; Jean-Paul Noben; Rob Lavigne; Zuzanna Drulis-Kawa
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

10.  The role of Proteus mirabilis cell wall features in biofilm formation.

Authors:  Grzegorz Czerwonka; Anna Guzy; Klaudia Kałuża; Michalina Grosicka; Magdalena Dańczuk; Łukasz Lechowicz; Dawid Gmiter; Paweł Kowalczyk; Wiesław Kaca
Journal:  Arch Microbiol       Date:  2016-06-04       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.